Ugeo H60 ultrasound system

Equanox Advance Model 7600 Regional Oximetry System

Tango M2 cardiac stress BP monitor

 Fujifilm Medical Systems USA, Inc. has introduced its Aspire product line of women’s health care solutions.

 TeamBest companies are planning for a major expansion by diversifying its area of expertise and product lines, to meet the growing demands of an increasing and aging population. Earlier this year, Best Medical International (BMI) purchased Envisioneering Medical Technologies’ assets including TargetScan Touch, an ultrasound based stereotactic biopsy guidance and tumor localization system. TargetScan data can be used to generate a predictive model of tumor locations and provide for micro-invasive curative techniques using EBRT (external beam radiation therapy) or brachytherapy or combination. Because of its ability to target and record biopsy locations the TargetScan Touch can provide for prostate cancer management protocols such as active surveillance and focal therapy.

Samsung Electronics America Inc. announced the Samsung Ugeo H60, the first ultrasound system integrating Samsung technology and design introduced to the U.S. medical imaging market. The Samsung Ugeo H60 ensures superior imaging performance and a sleek design that provides users with a fast, accurate and intuitive ultrasound experience.

Angiotech Pharmaceuticals Inc. announced that it entered into a definitive agreement to sell certain of its subsidiaries, comprising Angiotech's interventional products business, to Argon Medical Devices Inc., a portfolio company of RoundTable Healthcare Partners, for $362.5 million in cash consideration. Angiotech expects the transaction will close prior to the end of April 2013.

Toshiba America Medical Systems, Inc. has introduced Innovation 2013, new U.S. Food and Drug Administration (FDA)-cleared software advancements for the Aplio 500 and Aplio 300 ultrasound systems.


 In 2009, the Centers for Medicare and Medicaid Services (CMS) halted reimbursement for so-called “virtual colonoscopy” for routine colon-cancer screening in asymptomatic patients, in part due to concerns over how this procedure, computed tomography colonography (CTC), was being used in the elderly population.


Subscribe Now